Senior Vice President, CMC · Jade Biosciences, Inc. (JBIO)

Marinus Verwijs

FY2022 is the first fiscal year CompBrief holds for Marinus Verwijs as a named executive officer of Jade Biosciences; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2022

$1,262,075

Salary $290,000Stock awards $0

1st of 3 named executive officers at Jade Biosciences by FY2022 total.

3 named officers on file for Jade Biosciences, FY2022

Marinus Verwijs’s pay file — $29

  • 1 fiscal year of pay, line by line
  • JBIO’s disclosed peer group of 20 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how Jade Biosciences’s whole pay program stands against its peers

  • Jade Biosciences’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on JBIO→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 19, 2023 (DEF 14A).

Free

Get Marinus Verwijs’s pay history as a PDF, right here and by email

The PDF adds what this page leaves out: up to 10 years of pay, a peer comparison, and the board on one page. Two emails at most, nothing else.

Marinus Verwijs compensation by year

Jade Biosciences Summary Compensation Table · the one fiscal year held
In US dollars, as Jade Biosciences reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022
Salary$290,000
Bonus$0
Stock awards$0
Option awards$880,200
Non-equity incentive$91,875
Pension and deferred compensation$0
All other$0
Total$1,262,075

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Jade Biosciences, Inc. DEF 14A filed April 19, 2023, accession 0001798749-23-000028, and prior-year filings.

How this page was built: the Jade Biosciences, Inc. filed document, accession 0001798749-23-000028. Every figure is read from that document and cited to the page and table it appears in. Filed April 19, 2023.

Equity holdings

unvested awards at FY2022 year-end
TypeUnvested unitsValue at year-endExercise price
Option90,000—$14.59

Per the Outstanding Equity Awards at Fiscal Year-End table in Jade Biosciences, Inc.'s FY2022 proxy; value at the fiscal year-end close, as the company printed it.

Jade Biosciences’s named executive officers, FY2022

as the company reported each
Named executive officerRoleFY2022 total
Marinus Verwijs · this pageSenior Vice President, CMC$1,262,075
Timothy NoyesChief Executive Officer$703,800
George EldridgeChief Financial Officer$533,894

The full Jade Biosciences compensation record

free company brief

This page is one person within Jade Biosciences's record. The company brief lists every named executive, each linking to their own page.

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are Jade Biosciences's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Marinus Verwijs's compensation dossier · One-time report. No refunds.